It has been suggested that U2AF1 mutation was significantly associated with non-response to azacitidine, but for other spicing machinery genes, the results were negative.[16,47] More studies are needed for searching new precision therapeutic strategies for the MDS patients with splicing machinery gene mutations. Here, U2AF1 is linked to myelodysplastic syndrome.